The Firmament Group

The Firmament Group, commonly branded as Firmament, is a New York-based private investment firm and multi-strategy asset manager focused on providing tailored debt and equity capital to small- and medium-sized enterprises. The firm invests primarily across three verticals: healthcare, technology, and the environment, with healthcare activity centered on services, software, and specialty-manufacturing businesses rather than therapeutic drug development. Firmament offers control equity, minority equity, growth debt, unitranche, second lien, mezzanine, preferred equity, and common equity solutions to support buyouts, recapitalizations, acquisitions, refinancings, and growth financings. The business was established in 2012 and is active as a private company and SEC-registered investment adviser affiliate structure under the Firmament brand. For a biotech analyst, this is best understood not as a drug developer but as a healthcare-focused financial sponsor and capital provider to lower-middle-market companies.